Latest news
Marengo nominates first TriSTAR candidate under USD 1.2b Ipsen collaboration - AllSciAllSci · Wed, 05 Aug 2026 15:38:43 GMTFrom molecule to medicine: the process behind patient-ready treatments - IpsenIpsen · Wed, 05 Aug 2026 07:44:36 GMTMarengo Nominates First Drug Candidate Under Strategic TriSTAR Collaboration with Ipsen and Welcomes Industry-Leading T-Cell Engager Expert, Saso Cemerski, Ph.D., to Accelerate Pipeline Expansion - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 11:00:00 GMTIpsen bought back shares on July 27, 28 and 31, 2026 - Stock TitanStock Titan · Mon, 03 Aug 2026 16:12:47 GMTIPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2026 - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 16:00:00 GMTIpsen quietly returns cancer drug IPN01194 to AGV Discovery - European Biotechnology MagazineEuropean Biotechnology Magazine · Mon, 03 Aug 2026 15:51:30 GMTIpsen has ‘firepower’ for more deals with €2B war chest - Endpoints NewsEndpoints News · Thu, 30 Jul 2026 14:16:00 GMTIpsen raises 2026 outlook after strong first-half sales growth - The Pharma LetterThe Pharma Letter · Thu, 30 Jul 2026 12:02:43 GMT